Articles

First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013

Department of Oncology-Pathology, Karolinska Institutet, Stockholm
Department of Oncology-Pathology, Karolinska Institutet, Stockholm;Department of Oncology, Karolinska University Hospital, Stockholm
Department of Oncology-Pathology, Karolinska Institutet, Stockholm
Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund;Department of Translational Medicine, Lund University
Department of Hematology, Sahlgrenska University Hospital, Gothenburg
Department of Internal Medicine, Östersunds Hospital
Department of Internal Medicine Huddinge, Karolinska Institutet, Stockholm
Department of Internal Medicine Huddinge, Karolinska Institutet, Stockholm
Department of Hematology, South Älvsborg Hospital, Borås
Department of Oncology-Pathology, Karolinska Institutet, Stockholm;Department of Hematology, Karolinska University Hospital, Stockholm
Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund
Department of Hematology, Sunderby Hospital, Sunderbyn-Luleå
Department of Hematology, Uppsala University Hospital
Department of Hematology, Linköping University Hospital
Department of Medicine, Sundsvall Hospital, Sweden
Department of Oncology-Pathology, Karolinska Institutet, Stockholm;Department of Hematology, Karolinska University Hospital, Stockholm
Department of Oncology-Pathology, Karolinska Institutet, Stockholm;Department of Hematology, Karolinska University Hospital, Stockholm
Vol. 104 No. 4 (2019): April, 2019 https://doi.org/10.3324/haematol.2018.200204